-+ 0.00%
-+ 0.00%
-+ 0.00%
Update: Leo Pharma Pushes Back IPO Plans Past 2026, CEO Says
Share
Listen to the news
06:11 AM EST, 11/16/2026 (MT Newswires) -- (Updates with additional information) Leo Pharma shelved plans for an initial public offering in 2026, Bloomberg News reported Monday, citing Chief Executive Officer Christophe Bourdon. Bourdon said that the Danish pharmaceutical company is prepared for an IPO, but its shareholders determined that the current market conditions "do not support a listing.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending